Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier. (Q48290634)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

author name string

Nives Skrlj

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Gorazd Drevenšek

2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Samo Hudoklin

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Rok Romih

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Vladka Curin Šerbec

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

publication date

17 November 2012

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Applied Biochemistry and Biotechnology

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

169

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

159-169

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

https://scigraph.springernature.com/pub.10.1007/s12010-012-9962-7

0 references

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Engineered antibody approaches for Alzheimer's disease immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Drug targeting to the brain

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Cell-penetrating peptides.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Delivery of bioactive molecules into the cell: the Trojan horse approach

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Penetratin story: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Vaccine approaches to prevent and treat prion infection : progress and challenges

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Antibody variable-region sequencing as a method for hybridoma cell-line authentication

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

A versatile bacterial expression vector based on the synthetic biology plasmid pSB1.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administration

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Delivery of peptides to the brain: emphasis on therapeutic development

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Synthesis and studies on cell-penetrating peptides

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

High-level expression and purification of Tat-haFGF19-154.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Molecular basis for specificity of nuclear import and prediction of nuclear localization

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Prion (PrPSc)-specific epitope defined by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

A prion protein epitope selective for the pathologically misfolded conformation

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Therapeutic approaches for prion disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9962-7

21 January 2018

Identifiers

10.1007/S12010-012-9962-7

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23160949

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48290634&oldid=1577574016"